Literature DB >> 17955101

Refractory Clostridium difficile-associated diarrhea.

Shilpa Grover1, Matthew J Hamilton, David L Carr-Locke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17955101      PMCID： PMC1994858     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  19 in total

1.  Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.

Authors:  H Rüssmann; K Panthel; R-C Bader; C Schmitt; R Schaumann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

2.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 3.  Pseudomembranous colitis: pathogenesis and therapy.

Authors:  F J Tedesco
Journal:  Med Clin North Am       Date:  1982-05       Impact factor: 5.456

4.  Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.

Authors:  F Barbut; G Corthier; Y Charpak; M Cerf; H Monteil; T Fosse; A Trévoux; B De Barbeyrac; Y Boussougant; S Tigaud; F Tytgat; A Sédallian; S Duborgel; A Collignon; M E Le Guern; P Bernasconi; J C Petit
Journal:  Arch Intern Med       Date:  1996-07-08

5.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 6.  Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.

Authors:  Anucha Apisarnthanarak; Behzad Razavi; Linda M Mundy
Journal:  Clin Infect Dis       Date:  2002-08-26       Impact factor: 9.079

7.  High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Authors:  M Komatsu; H Kato; M Aihara; K Shimakawa; M Iwasaki; Y Nagasaka; S Fukuda; S Matsuo; Y Arakawa; M Watanabe; Y Iwatani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

8.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

Authors:  C Pothoulakis; J T LaMont; R Eglow; N Gao; J B Rubins; T C Theoharides; B F Dickey
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

10.  Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

Authors:  C P Kelly; S Becker; J K Linevsky; M A Joshi; J C O'Keane; B F Dickey; J T LaMont; C Pothoulakis
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808
View more
  1 in total

Review 1.  Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review.

Authors:  Marwan S Abougergi; John H Kwon
Journal:  Dig Dis Sci       Date:  2010-10-06       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.